4-MUST

DRUG3 trials

Sponsors

Valenta Pharm JSC

Conditions

Biliary DyskinesiaChronic Cholecystitis

Phase 1

Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers

RecruitingNCT07594977

Valenta Pharm JSCBiliary Dyskinesia, Chronic Cholecystitis

Start: 2026-01-26End: 2027-06-30Target: 45Updated: 2026-06-15

Phase 2

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

RecruitingNCT06842966

Valenta Pharm JSCBiliary Dyskinesia, Chronic Cholecystitis

Start: 2024-10-17End: 2026-12-31Target: 300Updated: 2025-07-11

Phase 3

Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia

RecruitingNCT07595003

Valenta Pharm JSCBiliary Dyskinesia, Chronic Cholecystitis

Start: 2025-12-12End: 2027-12-31Target: 300Updated: 2026-05-19